Trevi Therapeutics Financial Overview
Trevi Therapeutics's market cap is currently $1.67B. The company's EPS TTM is $-0.08; its P/E ratio is -35.04; Trevi Therapeutics is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is $-0.10. See an overview of income statement, balance sheet, and cash flow financials.
